Sign In
Buy ARDX
$6.18
-0.190 (-2.98%)
At Close: Jun 23, 2026
Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates
06:48pm, Thursday, 05'th May 2022
Ardelyx (ARDX) delivered earnings and revenue surprises of -5% and 87.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Best Penny Stocks to Buy as April Ends? 3 to Watch Today
01:31pm, Monday, 25'th Apr 2022 PennyStocks
Here's what you need to know about trading penny stocks on April 25th
The post Best Penny Stocks to Buy as April Ends? 3 to Watch Today appeared first on Penny Stocks to Buy, Picks, News and Informa
Why Ardelyx Shares Are Rising
11:45am, Monday, 25'th Apr 2022
Ardelyx Inc (NASDAQ: ARDX) shares are trading higher by 29.32% at $0.97 after the company reported it received an interim response from the OND, CDER and FDA for the company's second level of appeal o
FDA Plans To Convene AdComm For Ardelyx's Tenapanor For CKD Patients On Dialysis
11:29am, Monday, 25'th Apr 2022
The FDA's Office of New Drugs (OND), Center for Drug Evaluation and Research (CDER), has provided an interim response to Ardelyx Inc's (NASDAQ: ARDX) second level of appeal of the Complete Respons
Best Penny Stocks to Buy as April Ends? 3 to Watch Today
09:31am, Monday, 25'th Apr 2022
Here's what you need to know about trading penny stocks on April 25th The post Best Penny Stocks to Buy as April Ends? 3 to Watch Today appeared first on Penny Stocks to Buy, Picks, News and Informa
Kyowa Kirin To Cut Royalty Payment Rate To Ardelyx For Tenapanor In Cardiorenal Disorders
01:30pm, Monday, 11'th Apr 2022
Ardelyx Inc (NASDAQ: ARDX) has amended its license agreement, initially executed in 2017, granting Kyowa Kirin exclusive rights to develop and commercialize Ardelyx's tenapanor for cardiorenal dis
Hot Biotech Penny Stocks to Watch During the First Full Week of April
08:41pm, Monday, 04'th Apr 2022 PennyStocks
Can these biotech penny stocks continue to make gains?
The post Hot Biotech Penny Stocks to Watch During the First Full Week of April appeared first on Penny Stocks to Buy, Picks, News and Informati
Hot Biotech Penny Stocks to Watch During the First Full Week of April
04:41pm, Monday, 04'th Apr 2022
Can these biotech penny stocks continue to make gains? The post Hot Biotech Penny Stocks to Watch During the First Full Week of April appeared first on Penny Stocks to Buy, Picks, News and Informati
Good Penny Stocks To Watch During the Bear Market Right Now?
09:44pm, Monday, 07'th Mar 2022 PennyStocks
Which penny stocks are you watching right now?
The post Good Penny Stocks To Watch During the Bear Market Right Now? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Good Penny Stocks To Watch During the Bear Market Right Now?
04:44pm, Monday, 07'th Mar 2022
Which penny stocks are you watching right now? The post Good Penny Stocks To Watch During the Bear Market Right Now?
Are These Penny Stocks on Your Buy List Right Now? 3 to Watch
10:42pm, Thursday, 03'rd Mar 2022 PennyStocks
Which penny stocks are on your March 2022 watchlist as volatility continues?
The post Are These Penny Stocks on Your Buy List Right Now? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News
Are These Penny Stocks on Your Buy List Right Now? 3 to Watch
05:42pm, Thursday, 03'rd Mar 2022
Which penny stocks are on your March 2022 watchlist as volatility continues? The post Are These Penny Stocks on Your Buy List Right Now?
Ardelyx to Participate at the Cowen 42nd Annual Health Care Conference
11:55pm, Wednesday, 02'nd Mar 2022 PR Newswire
WALTHAM, Mass., March 2, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president…
Jefferies Raises Price Target On This Small-Cap 'Stand Out' Biotech Stock
06:54pm, Wednesday, 02'nd Mar 2022 Benzinga
Ardelyx Inc (NASDAQ: ARDX) shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target on the stock to $5 from $1.
Analyst Chris Howerton thinks Ardelyx "s
Jefferies Raises Price Target On This Small-Cap ''Stand Out'' Biotech Stock
06:54pm, Wednesday, 02'nd Mar 2022 Benzinga
Ardelyx Inc (NASDAQ: ARDX ) shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target on the stock to $5 from $1 . Analyst Chris Howerton thinks Ardelyx "stands out" given that the Company has an approved IBS-C product, Isbrela, that will launch in April and whose commercial opportunity is validated by Linzess and Trulance. Ironwood Pharmaceuticals Inc (NASDAQ: IRWD ) and AbbVie Inc''s (NYSE: ABBV ) Linzess achieved $1 billion in sales in 2021, while Salix Pharmaceuticals'' Trulance achieved … Full story available on Benzinga.com
